Medical/pharmaceutical supplier McKesson had a good fiscal year 2015 across many of its operations, but its health information technology business continues to struggle.

In the fourth quarter ending March 31, McKesson in its entirety had revenue of $44.9 billion, up 19 percent from the year-ago quarter. And for the full fiscal year, revenue rose 30 percent to $179 billion with GAAP earnings per diluted shares from continuing operations of $7.54, up 24 percent. Further, the company projects 12 to 16 percent in earnings per share for fiscal 2016.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access